Abiopharma

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest of Director - Toh Ker How

General Announcement: INCORPORATION OF NEW SUBSIDIARY IN THE UNITED ARAB EMIRATES

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

BrainsWay Presents Positive Data from Largest Real-World Study of Deep TMS™ in Patients with Comorbid PTSD and Major Depressive Disorder

Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program

Streamex Corp. Brings Yield-Bearing Gold (GLDY) to Traditional Brokerage Accounts Through Collaboration with Siebert Financial and tZERO

Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves Disease

Twin Disc, Inc. Joins Russell 2000® and Russell 3000® Indexes

HONEYWELL TECHNOLOGIES TO RELEASE SECOND QUARTER FINANCIAL RESULTS, DISCUSS 2026 OUTLOOK AND HOLD ITS INVESTOR CONFERENCE CALL ON THURSDAY, JULY 23

FreightCar America, Inc. Joins Russell 2000® and Russell 3000® Indexes